Related Experiment Video
Updated: May 9, 2026

13:43
Correlative Microscopy for 3D Structural Analysis of Dynamic Interactions
Published on: June 24, 2013
Catching HIV 'in the act' with 3D electron microscopy.
Lesley A Earl1, Jeffrey D Lifson, Sriram Subramaniam
1Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Trends in Microbiology
|July 16, 2013
Summary
Developing an effective human immunodeficiency virus (HIV) vaccine is crucial for global health. Understanding HIV's complex structure using 3D electron microscopy aids in designing better vaccines and understanding viral entry.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- Controlling the global human immunodeficiency virus (HIV) epidemic requires a safe and effective vaccine.
- HIV's diverse envelope glycoproteins and inaccessible epitopes present significant challenges for vaccine development.
- Understanding viral structure is critical for designing effective HIV vaccines.
Purpose of the Study:
- To review recent advancements in understanding HIV structure.
- To explore the application of 3D electron microscopy in HIV research.
- To discuss how structural insights can inform HIV vaccine design and viral entry mechanisms.
Main Methods:
- Review of current scientific literature on HIV structure and vaccine design.
- Focus on emerging 3D electron microscopy techniques.
- Analysis of structural data of HIV surface envelope glycoproteins.
Main Results:
- 3D electron microscopy provides unprecedented structural detail of HIV.
- Structural variability of envelope glycoproteins is a major hurdle for vaccine design.
- Identification of neutralization-sensitive epitopes is crucial for developing effective vaccines.
Conclusions:
- Advances in structural biology, particularly 3D electron microscopy, offer new avenues for HIV vaccine research.
- A deeper understanding of HIV's structure is essential for overcoming challenges in vaccine design.
- Future HIV vaccine strategies may benefit from targeting specific structural features revealed by advanced imaging techniques.
